vs
Alector, Inc.(ALEC)与FLEXIBLE SOLUTIONS INTERNATIONAL INC(FSI)财务数据对比。点击上方公司名可切换其他公司
FLEXIBLE SOLUTIONS INTERNATIONAL INC的季度营收约是Alector, Inc.的1.5倍($9.1M vs $6.2M),FLEXIBLE SOLUTIONS INTERNATIONAL INC同比增速更快(-0.5% vs -88.5%),FLEXIBLE SOLUTIONS INTERNATIONAL INC自由现金流更多($-4.0M vs $-184.1M),过去两年FLEXIBLE SOLUTIONS INTERNATIONAL INC的营收复合增速更高(-0.6% vs -37.4%)
Alector是一家临床阶段生物制药企业,专注于神经退行性疾病的免疫疗法研发,管线覆盖阿尔茨海默病、额颞叶痴呆、帕金森病等未被满足的医疗需求,主要在美国运营,与全球药企合作推进候选药物的临床试验。
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业,核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等,服务北美及全球农业、水务领域客户。
ALEC vs FSI — 直观对比
营收规模更大
FSI
是对方的1.5倍
$6.2M
营收增速更快
FSI
高出88.0%
-88.5%
自由现金流更多
FSI
多$180.0M
$-184.1M
两年增速更快
FSI
近两年复合增速
-37.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $6.2M | $9.1M |
| 净利润 | — | $-460.9K |
| 毛利率 | — | 29.4% |
| 营业利润率 | — | 11.6% |
| 净利率 | — | -5.1% |
| 营收同比 | -88.5% | -0.5% |
| 净利润同比 | -1696.9% | -167.8% |
| 每股收益(稀释后) | — | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ALEC
FSI
| Q4 25 | $6.2M | $9.1M | ||
| Q3 25 | $3.3M | $10.6M | ||
| Q2 25 | $7.9M | $11.4M | ||
| Q1 25 | $3.7M | $7.5M | ||
| Q4 24 | $54.2M | $9.2M | ||
| Q3 24 | $15.3M | $9.3M | ||
| Q2 24 | $15.1M | $10.5M | ||
| Q1 24 | $15.9M | $9.2M |
净利润
ALEC
FSI
| Q4 25 | — | $-460.9K | ||
| Q3 25 | $-34.7M | $-503.4K | ||
| Q2 25 | $-30.5M | $2.0M | ||
| Q1 25 | $-40.5M | $-277.7K | ||
| Q4 24 | $-2.1M | $679.6K | ||
| Q3 24 | $-42.2M | $611.9K | ||
| Q2 24 | $-38.7M | $1.3M | ||
| Q1 24 | $-36.1M | $457.2K |
毛利率
ALEC
FSI
| Q4 25 | — | 29.4% | ||
| Q3 25 | — | 23.9% | ||
| Q2 25 | — | 47.4% | ||
| Q1 25 | — | 26.1% | ||
| Q4 24 | — | 29.2% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 37.4% | ||
| Q1 24 | — | 30.6% |
营业利润率
ALEC
FSI
| Q4 25 | — | 11.6% | ||
| Q3 25 | -1153.6% | 2.9% | ||
| Q2 25 | -433.6% | 29.0% | ||
| Q1 25 | -1216.5% | -0.9% | ||
| Q4 24 | -13.4% | 9.4% | ||
| Q3 24 | -315.7% | 20.5% | ||
| Q2 24 | -302.4% | 18.7% | ||
| Q1 24 | -275.0% | 8.3% |
净利率
ALEC
FSI
| Q4 25 | — | -5.1% | ||
| Q3 25 | -1063.4% | -4.8% | ||
| Q2 25 | -387.7% | 17.8% | ||
| Q1 25 | -1101.6% | -3.7% | ||
| Q4 24 | -3.8% | 7.4% | ||
| Q3 24 | -275.2% | 6.6% | ||
| Q2 24 | -256.4% | 12.3% | ||
| Q1 24 | -227.0% | 5.0% |
每股收益(稀释后)
ALEC
FSI
| Q4 25 | — | $-0.03 | ||
| Q3 25 | $-0.34 | $-0.04 | ||
| Q2 25 | $-0.30 | $0.15 | ||
| Q1 25 | $-0.41 | $-0.02 | ||
| Q4 24 | $-0.02 | $0.05 | ||
| Q3 24 | $-0.43 | $0.05 | ||
| Q2 24 | $-0.40 | $0.10 | ||
| Q1 24 | $-0.38 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $256.0M | — |
| 总债务越低越好 | $10.0M | $4.4M |
| 股东权益账面价值 | $30.6M | $38.9M |
| 总资产 | $293.2M | $61.8M |
| 负债/权益比越低杠杆越低 | 0.33× | 0.11× |
8季度趋势,按日历期对齐
现金及短期投资
ALEC
FSI
| Q4 25 | $256.0M | — | ||
| Q3 25 | $291.1M | — | ||
| Q2 25 | $307.3M | $10.0M | ||
| Q1 25 | $354.6M | $11.0M | ||
| Q4 24 | $413.4M | $10.0M | ||
| Q3 24 | $457.2M | $13.0M | ||
| Q2 24 | $503.3M | $9.2M | ||
| Q1 24 | $562.1M | $8.3M |
总债务
ALEC
FSI
| Q4 25 | $10.0M | $4.4M | ||
| Q3 25 | — | $7.1M | ||
| Q2 25 | — | $7.5M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | $10.0M | $8.8M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | — | $8.0M |
股东权益
ALEC
FSI
| Q4 25 | $30.6M | $38.9M | ||
| Q3 25 | $57.7M | $39.0M | ||
| Q2 25 | $71.2M | $39.4M | ||
| Q1 25 | $94.6M | $38.4M | ||
| Q4 24 | $126.8M | $38.0M | ||
| Q3 24 | $118.9M | $36.9M | ||
| Q2 24 | $150.6M | $36.2M | ||
| Q1 24 | $178.9M | $36.0M |
总资产
ALEC
FSI
| Q4 25 | $293.2M | $61.8M | ||
| Q3 25 | $335.3M | $58.4M | ||
| Q2 25 | $356.4M | $58.2M | ||
| Q1 25 | $408.3M | $61.7M | ||
| Q4 24 | $468.3M | $60.0M | ||
| Q3 24 | $516.0M | $57.8M | ||
| Q2 24 | $570.7M | $56.3M | ||
| Q1 24 | $635.5M | $57.6M |
负债/权益比
ALEC
FSI
| Q4 25 | 0.33× | 0.11× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | 0.08× | 0.23× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-184.0M | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | $-184.1M | $-4.0M |
| 自由现金流率自由现金流/营收 | -2951.3% | -44.3% |
| 资本支出强度资本支出/营收 | 0.7% | 11.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-326.5M | $-591.7K |
8季度趋势,按日历期对齐
经营现金流
ALEC
FSI
| Q4 25 | $-184.0M | $-3.0M | ||
| Q3 25 | $-32.5M | $2.0M | ||
| Q2 25 | $-49.0M | $5.3M | ||
| Q1 25 | $-60.8M | $-544.3K | ||
| Q4 24 | $-55.0M | $-2.2M | ||
| Q3 24 | $-50.7M | $2.5M | ||
| Q2 24 | $-62.8M | $5.9M | ||
| Q1 24 | $-61.3M | $-604.8K |
自由现金流
ALEC
FSI
| Q4 25 | $-184.1M | $-4.0M | ||
| Q3 25 | $-32.5M | $39.4K | ||
| Q2 25 | $-49.1M | $4.3M | ||
| Q1 25 | $-60.8M | $-898.4K | ||
| Q4 24 | $-55.2M | $-4.3M | ||
| Q3 24 | $-50.9M | $1.3M | ||
| Q2 24 | $-63.1M | $4.7M | ||
| Q1 24 | $-61.9M | $-1.1M |
自由现金流率
ALEC
FSI
| Q4 25 | -2951.3% | -44.3% | ||
| Q3 25 | -997.6% | 0.4% | ||
| Q2 25 | -623.0% | 37.9% | ||
| Q1 25 | -1655.0% | -12.0% | ||
| Q4 24 | -101.8% | -47.0% | ||
| Q3 24 | -332.1% | 13.6% | ||
| Q2 24 | -418.6% | 44.9% | ||
| Q1 24 | -389.3% | -11.7% |
资本支出强度
ALEC
FSI
| Q4 25 | 0.7% | 11.7% | ||
| Q3 25 | 0.3% | 18.7% | ||
| Q2 25 | 0.1% | 8.6% | ||
| Q1 25 | 0.5% | 4.7% | ||
| Q4 24 | 0.3% | 22.8% | ||
| Q3 24 | 1.4% | 13.0% | ||
| Q2 24 | 2.2% | 11.3% | ||
| Q1 24 | 3.4% | 5.2% |
现金转化率
ALEC
FSI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.60× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.27× | ||
| Q3 24 | — | 4.05× | ||
| Q2 24 | — | 4.59× | ||
| Q1 24 | — | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图